Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T. Kim(Dana-Farber Cancer Institute), Michael R. Grunwald(Levine Cancer Institute), Robert S. Negrin(Stanford University), Brian T. Hill(Cleveland Clinic), Sunita Nathan(Rush University Medical Center), Steven M. Devine(National Marrow Donor Program), Mehdi Hamadani(Medical College of Wisconsin), Mohamed L. Sorror(University of Washington Medical Center), Attaphol Pawarode(University of Michigan), Nakhle S. Saba(Tulane Medical Center), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Edward A. Copelan(Levine Cancer Institute), Gerhard Hildebrandt(University of Missouri Health System), Oliver W. Press(Fred Hutch Cancer Center), Yoshihiro Inamoto, Zhen‐Huan Hu(Medical College of Wisconsin), Harry C. Schouten, Amer Beitinjaneh(University of Miami), Stephen J. Forman(City Of Hope National Medical Center), Jan Černý(Worcester Memorial Hospital), Hillard M. Lazarus(University Hospitals of Cleveland), Mazyar Shadman(University of Washington), Joseph P. McGuirk(University of Kansas Medical Center), Amelia Langston(CancerCare Manitoba), Joseph H. Antin(Dana-Farber Cancer Institute), Matthew S. Davids(Dana-Farber Cancer Institute), Richard A. Nash(Colorado Blood Cancer Institute), Virginia O. Volpe(UConn Health), Ulrike Bacher(Hattiesburg Clinic), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Minoo Battiwalla(Sarah Cannon), Nilanjan Ghosh(Levine Cancer Institute), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), William J. Hogan(Mayo Clinic), Ran Reshef(Abramson Cancer Center), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Jayesh Mehta(Midwestern University), Jean‐Yves Cahn(Université Grenoble Alpes), Edward Agura(Baylor University), Joseph P. Uberti(Sheba Medical Center), Sid Ganguly(The University of Kansas Health System), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Tamila L. Kindwall‐Keller(MetroHealth Medical Center), Joseph Pidala(Moffitt Cancer Center), Kwang Woo Ahn(Medical College of Wisconsin), Gregory A. Hale(Johns Hopkins University), Melhem Solh(Johns Hopkins Hospital)
Cited by 13
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k